GLP-1 drugs are changing lives. But the science is clear. If you don’t do strength training, you won’t just lose weight.
Health and Wellness · March 2026
If you’re taking GLP-1 drugs like Ozempic, Wegovy, or Mounjaro, you already know the appeal. The weight will go away. Cravings subside. I feel like the deck is finally stacked in my favor. And that is that these are really effective drugs.
But here’s something important. The weight you’re losing isn’t all fat. A significant portion comes from lean body mass, including muscle. Without a strategy to maintain lean body mass, over time this can lead to a decline in muscle strength and functional capacity.
The good news? This fix doesn’t require hours of gym time. Doing short, continuous resistance exercises helps maintain muscle mass. Here’s what the research shows:
The hidden costs of GLP-1 weight loss
Studies on semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have consistently found that: Between 25% and 40% of the weight lost with these drugs is lean body mass. — This includes your muscles. The landmark STEP 1 trial of semaglutide found that approximately 40% of the total body weight lost was from lean tissue rather than fat. It’s not for nothing.
25-40%
GLP-1-induced weight loss may be driven by lean muscle mass rather than fat
30%
GLP-1 users and non-users have a potentially higher risk of osteoporosis
~1/8
Adults in the United States are currently taking GLP-1 drugs
10 minutes
Daily strength training can meaningfully preserve muscles and bones.
Why is this important? Muscles play an important role in metabolic health, strength, mobility, and long-term function. Loss of lean body mass can increase your risk of fatigue, muscle weakness, and frailty over time.
New research: GLP-1 and bone risk
Several new studies are investigating the potential effects of GLP-1 drugs on bone health. The result is mixed and inconclusiveWeight loss itself, regardless of the method, leads to a decrease in bone density. Both reduced caloric intake and reduced mechanical load contribute.
Exercise, especially resistance and weight-bearing exercise, is one of the most evidence-based ways to help maintain bone density during weight loss.
Why resistance training is non-negotiable
Resistance training is one of the most effective tools for maintaining muscle and bone during weight loss.
Randomized clinical trial published in JAMA Network Open (2024) When you combine GLP-1 therapy with exercise, Better preservation of bone density Comparison with GLP-1 therapy alone.
“It seems very prudent to implement targeted exercise to preserve and potentially increase muscle mass in patients undergoing GLP-1-based therapy.”
— Frontiers in Endocrinology, 2024
Another case series published in PMC showed that GLP-1 users who did structured resistance training three to five days a week not only maintained muscle, but some patients actually increased lean body mass while significantly reducing body fat. That’s the difference between losing weight and truly changing your body composition.
The conclusion of the study is that this drug reduces fat. It saves muscle.
This is where microdosing workouts come in.
People taking GLP-1 drugs are often looking for the most effective and least labor intensive method. That’s not criticism, it’s wisdom. These drugs work because they lower the threshold for success. Microdosing workouts follow the same philosophy.
You don’t need a 60-minute gym session to protect your muscle mass. According to research, Short, frequent resistance exercises Even short sessions of 5 to 10 minutes at a time stimulate the muscle-maintaining responses your body needs. A 2025 study from Edith Cowan University found that five minutes of daily bodyweight training can help improve strength, flexibility, and mood, even for people who rarely exercise.
“People taking GLP-1 drugs already have the tools for appetite and fat loss. Resistance training complements this by helping maintain muscle.”
— Evidence-based consensus across exercise physiology research
Think of it as a combination of two efficiency tools. Medicines reduce calories. Protect your muscles and bones with short daily workouts. When the two work together, they achieve results that cannot be achieved by either alone.
what your day looks like
GLP-1 friendly microdose resistance exercise (5-10 minutes each)
- Do wall push-ups or floor push-ups (3 sets of 10-15 reps) while making coffee.
- Bodyweight squats or chair squats – great for quads and glutes
- Lay out your resistance bands or do curls at your desk or in front of the TV.
- Fast-paced stair climbing – one of the most studied bone-protecting activities
- slow controlled lunges while on the phone
- Plank Hold (20-30 seconds) — Build core strength without hitting the gym.
- Raise your heels when standing on the kitchen counter, protecting your ankle and calf muscles
No weights required. No gym membership required. It just takes consistency and a little effort in the right direction. Taking these “microdoses” just three to four times a week can make a huge difference to your muscle and bone health over time.
takeout
GLP-1 drugs are powerful tools. However, tools are most effective when used correctly. The research is clear: Without some form of resistance exercise, you risk losing the muscle and bone density you need for a long, healthy life. And with microdosing workouts, there are no more hurdles.
10 minutes. Several times a week. No gym required. Just as your medicine rarely asks you for big rewards each week, so too does this.
Scale is only part of the story. Make sure the rest of the story is a good one.
The research behind this article
- Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment (JAMA Network Open, 2024) — 52-week RCT involving 195 adults. Exercise + GLP-1 therapy maintained bone density in the hip, spine, and forearm, whereas GLP-1 therapy alone decreased bone density.
- Preserving firm soft tissue during weight loss with GLP-1 therapy (PMC, 2025) — Shows a case series where GLP-1 users who combined resistance training (3-5 days per week) with adequate protein actually increased lean soft tissue while minimizing muscle loss or reducing fat.
- GLP-1 may increase osteoporosis risk, new study finds (AAOS/NBC News, 2026) — A large retrospective study presented at the American Academy of Orthopedic Surgeons found that GLP-1 users had an approximately 30% higher incidence of osteoporosis and nearly doubled their risk of bone density problems over five years.
- Muscle mass and GLP-1 receptor agonists: adaptive or maladaptive response? (Published in 2024) —Comprehensive review from the Journal of the American Heart Association. Semaglutide was associated with lean body mass loss of up to 40% of total body weight lost in the STEP 1 trial. It highlights the importance of targeted lifestyle interventions.
- GLP-1 and lean body mass: What the research shows (ACE Fitness, 2025) — Analysis of genetic studies involving more than 800,000 people confirms that GLP-1 reduces both fat and lean body mass, but fat loss is more dramatic. To maintain muscle, we recommend resistance training 2-3 times per week and a daily protein target of 1.2-1.6 g/kg.
This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or care team before changing your exercise habits while taking any medication.
